Interrupting Metsera bidding process would be wrong, Delaware judge says
A ruling on a pending motion from Pfizer to block a bid by Novo Nordisk to buy Metsera during the ongoing bidding process would be wrong, according to a Delaware Court...To view the full article, register now.
Already a subscriber? Click here to view full article